Source: Eur Respir J 2011; 38: 1238-1239
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Diel R., Goletti D., Lange C., Manissero D.. Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection. Eur Respir J 2011; 38: 1238-1239

Member's Comments

No comment yet.

Related content which might interest you: Interferon-gamma release assays for the diagnosis of latent Mycobacterium tuberculosis infection Source: Eur Respir J 2011; 38: 1237-1238 Year: 2011 Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis Source: Eur Respir J 2007; 30: 321-332 Year: 2007 Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis Source: Eur Respir J 2007; 30: 722-728 Year: 2007 Direct costs of three models for the screening of latent tuberculosis infection Source: Eur Respir J 2006; 28: 45-50 Year: 2006 Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection Source: Eur Respir J 2006; 28: 24-30 Year: 2006 Beyond the IFN-? horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis Source: Eur Respir J 2014; 43: 1472-1486 Year: 2014 Contribution of a whole blood IFN-gamma release assay for diagnosis of M. tuberculosis infection in BCG-vaccinated children Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment Year: 2008 Comparison of T-cell interferon-γ release assay to mycobacterium tuberculosis-specific antigens in patients with active and latent tuberculosis Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013 Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test Source: Eur Respir J 2006; 28: 16-23 Year: 2006 Interferon-γ release assays for the diagnosis of latent tuberculosis infection in HIV-seropositive individuals Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 Update: T-cell interferon-gamma release assays for the diagnosis of MTB infection Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course Year: 2008 Comparison of two in vitro IFN-γ assays for detection of latent tuberculosis infection Source: Eur Respir J 2006; 28: Suppl. 50, 343s Year: 2006 Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) Year: 2008 LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Source: Eur Respir J 2009; 33: 956-973 Year: 2009 What is latent tuberculosis infection (LTBI)? Source: Annual Congress 2009 - Microbial colonisation or latency: a foot in the door to respiratory infections Year: 2009 Diagnosis of latent tuberculosis infection Source: ERS Live 2007 Year: 2007 Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease Source: Eur Respir J 2006; 28: Suppl. 50, 139s Year: 2006 Interferon-gamma release assays (IGRA) for latent tuberculosis infection (LTBI) in children Source: Annual Congress 2011 - Tuberculosis in pregnancy and childhood Year: 2011 Diagnosis and treatment of latent tuberculosis infection Source: Eur Respir Monogr 2018; 82: 381-398 Year: 2018